Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $824000.0.

  • Aspen Aerogels' Current Deferred Revenue fell 6573.8% to $824000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $824000.0, marking a year-over-year decrease of 6573.8%. This contributed to the annual value of $2.2 million for FY2024, which is 505.18% down from last year.
  • Per Aspen Aerogels' latest filing, its Current Deferred Revenue stood at $824000.0 for Q3 2025, which was down 6573.8% from $624000.0 recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Current Deferred Revenue ranged from a high of $11.6 million in Q1 2021 and a low of $624000.0 during Q2 2025
  • Over the past 5 years, Aspen Aerogels' median Current Deferred Revenue value was $4.6 million (recorded in 2023), while the average stood at $5.4 million.
  • In the last 5 years, Aspen Aerogels' Current Deferred Revenue plummeted by 427.26% in 2021 and then crashed by 7983.84% in 2025.
  • Aspen Aerogels' Current Deferred Revenue (Quarter) stood at $11.0 million in 2021, then plummeted by 47.09% to $5.8 million in 2022, then plummeted by 60.38% to $2.3 million in 2023, then dropped by 5.05% to $2.2 million in 2024, then tumbled by 62.53% to $824000.0 in 2025.
  • Its Current Deferred Revenue was $824000.0 in Q3 2025, compared to $624000.0 in Q2 2025 and $2.6 million in Q1 2025.